Cargando…
Efficacy and safety of the noradrenaline reuptake inhibitor, TAS‐303, in women with stress urinary incontinence: Results of a double‐blind, randomized, placebo‐controlled, early phase II trial
OBJECTIVE: To carry out an exploratory assessment of the efficacy and safety of TAS‐303, a noradrenaline reuptake inhibitor, in women with stress urinary incontinence. METHODS: In a double‐blind, placebo‐controlled, early phase II study, women with stress urinary incontinence and stress urinary inco...
Autores principales: | Takahashi, Satoru, Kato, Kumiko, Takei, Mineo, Yokoyama, Osamu, Gotoh, Momokazu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821236/ https://www.ncbi.nlm.nih.gov/pubmed/33145841 http://dx.doi.org/10.1111/iju.14411 |
Ejemplares similares
-
TAS-303 effects on urethral sphincter function in women with stress urinary incontinence: phase I study
por: Yono, Makoto, et al.
Publicado: (2020) -
Efficacy of vibegron, a novel β3‐adrenoreceptor agonist, on severe urgency urinary incontinence related to overactive bladder: post hoc analysis of a randomized, placebo‐controlled, double‐blind, comparative phase 3 study
por: Yoshida, Masaki, et al.
Publicado: (2020) -
Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia
por: Welsch, Patrick, et al.
Publicado: (2018) -
Efficacy of TAC-302 for patients with detrusor underactivity and overactive bladder: a randomized, double-blind, placebo-controlled phase 2 study
por: Yoshida, Masaki, et al.
Publicado: (2022) -
Serotonin and Noradrenaline Reuptake Inhibitors Improve Micturition Control in Mice
por: Redaelli, Marco, et al.
Publicado: (2015)